Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT03120676 · TERMINATED
Trial details
- NCT number
- NCT03120676
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-14
- Primary completion
- 2018-11-12
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.